Amarin Non-GAAP EPS of -$0.02 beats by $0.38, revenue of $42.02M misses by $8.73M
Source: SeekingAlpha
2025-05-07 07:02:03 ET
More on Amarin
- Amarin Corporation plc (AMRN) Q4 2024 Earnings Call Transcript
- Amarin gains amid shareholder group push for strategic review
- Amarin to execute ADS ratio change
- Seeking Alpha’s Quant Rating on Amarin
- Historical earnings data for Amarin
Read the full article on Seeking Alpha
For further details see:
Amarin Non-GAAP EPS of -$0.02 beats by $0.38, revenue of $42.02M misses by $8.73M
Amarin Corporation plc
NASDAQ: AMRN
AMRN Trading
3.48% G/L:
$14.88 Last:
39,969 Volume:
$14.58 Open:
AMRN Latest News
March 18, 2026 08:30:00 am
Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline
March 07, 2026 01:35:00 am
Here's Why I Wouldn't Touch Amarin With a 10?Foot Pole Given Its Patent and Competition Risks
AMRN Stock Data
$312,618,004
18,426,477
1.2%
30
N/A
Pharmaceuticals
Healthcare
IE
Dublin 2
